While total phishing volume declined for the second year in a row, ThreatLabz identified 413,524 AI-generated site instances, underscoring how quickly adversaries can scale high-fidelity phishing News Highlights Quality Over Quantity: Phishing volume fell 20% for the second year in a row as attackers recalibrate to high-fidelity, AI-accelerated lures. Services Sector Surge: Targeted hits against the Services sector jumped 65.5%, as adversaries exploit trust-based workflows like billing and renewals. The Encryption Blind Spot: 95.2% of phishing attempts now hide in encrypted traffic, bypassing legacy security stacks that lack deep TLS inspection. “Text-to-Site” Weaponization: ThreatLabz identified over 413,000 AI-generated phishing instances, proving how easily attackers can now spin up polished, malicious sites. MFA Under...

MIAMI, FL, June 10, 2026 (GLOBE NEWSWIRE) — Core AI Holdings, Inc. (NASDAQ:CHAI) (“Core AI” or the “Company”), a global AI infrastructure and technology platform, today announced that it has entered into a securities purchase agreement with a new fundamental institutional investor for the purchase and sale of the Company’s 1,969,444 common shares and 3,975,000 pre-funded warrants for an aggregate price of approximately $5.4 million before deducting commissions and expenses of the offering. The Company plans to use the proceeds from the offering for advancement of its AI technology and infrastructure initiatives, and general working capital purposes. The closing of the offering is expected to occur on or about June 11, 2026, subject to the satisfaction of customary closing conditions. D. Boral Capital LLC...

TORONTO, June 10, 2026 (GLOBE NEWSWIRE) — As previously announced by Allied Gold Corporation (“Allied Gold” or the “Company”) (TSX: AAUC, NYSE: AAUC) on May 29 and Zijin Gold International Company Limited (“Zijin Gold”) on May 31, both parties remain fully committed to fulfilling the conditions for completion of the Arrangement by the extended outside date of July 29, 2026. In parallel, Allied has also remained focused on advancing the Company’s mining assets and delivering on its commitment to host-nation Governments and local stakeholders to advance its mine optimizations and project development. The Company is pleased to provide an update on mine life extension, mineral inventory growth, and optimization initiatives across its Côte d’Ivoire operations (“CDI Complex”), along with an update on the significant...

In addition to the A$6.0 million refund received, the Company expects a further approximately A$5.1 million in R&D Tax Incentive proceeds later this year, bringing total expected non-dilutive funding under the program to more than A$11.1 million received in 2026 NEW YORK and MELBOURNE, Australia, June 10, 2026 (GLOBE NEWSWIRE) — Incannex Healthcare Inc. (Nasdaq: IXHL) (“Incannex” or the “Company”), a clinical-stage biopharmaceutical company advancing innovative combination therapies and psychedelic-assisted treatments, is pleased to announce that it has received A$6,039,162.43 under the Australian Government’s Research and Development Tax Incentive Program. The Company also expects to receive an additional approximately A$5.1 million in future R&D Tax Incentive proceeds to be received in 2026. Combined, these proceeds...

HOUSTON, June 10, 2026 (GLOBE NEWSWIRE) — Koil Energy Solutions, Inc. (OTCQB: KLNG), (the “Company”), a leader in providing controls infrastructure for subsea oil and gas fields, today announced that it will be presenting at the Planet MicroCap Las Vegas 2026 Powered by MicroCapClub on Wednesday, June 17, 2026 at 2:30pm (PST) at the Bellagio Resort & Hotel. Erik Wiik, President and CEO, and Kurt Keller, Chief Financial Officer, will deliver the presentation and host a question-and-answer session immediately following. To access the live presentation, please use the following information: Planet MicroCap Showcase: Vegas 2026Presentation Date: Wednesday, June 17, 2026Presentation Time: 2:30pm (PST)Location: Bellagio Resort & Hotel, Las Vegas, NV, in Track 5 – Raphael 2Webcast: https://event.summitcast.com/view/bpjo3VVjZ25pp6SXpUua92/mDujgDyHN9g7g7BSsHC5e7 If...

Raanana, Israel, June 10, 2026 (GLOBE NEWSWIRE) — Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development-stage biotech company specializing in the development of innovative intranasal hydrogels, today announced that the European Patent Office (EPO) has completed the technical preparations for the publication of the Company’s European patent application entitled “Mucoadhesive Polymers for Nasal Drug Delivery.” The application was published under European publication number EP 4751737. The patent application covers Polyrizon’s proprietary Trap & Target™ (T&T) mucoadhesive polymer technology platform for nasal drug delivery. The technology is designed to enhance the interaction between pharmaceutical formulations and the nasal mucosa, potentially increasing formulation retention, improving...

Artelo’s lead medicinal chemist reveals findings at the Royal Society of Chemistry-BMCS/DMDG Medicinal Chemistry Conference in London SOLANA BEACH, Calif., June 10, 2026 (GLOBE NEWSWIRE) — Artelo Biosciences, Inc. (Nasdaq: ARTL) (“Artelo” or the “Company”), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatological, or neurological conditions, announces that Myles Osborn, Lead Medicinal Chemist at Artelo, is delivering an oral presentation today highlighting encouraging metabolite identification and profiling data from the Company’s lead FABP inhibitor candidate, ART26.12, during the 7th RSC-BMCS/DMDG New Perspectives in DMPK and Medicinal Chemistry Conference, held at the Burlington House in London. The presentation features...